McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Read More…
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Phone972-446-4800
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$214.32 billion
Profitability
Miscellaneous
Employees80,000
Next Earnings Date10/24/2019 (Estimated)
OptionableOptionable
McKesson (NYSE:MCK) Frequently Asked Questions
What is McKesson's stock symbol?
McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson pay dividends? What is the dividend yield for McKesson?
McKesson announced a quarterly dividend on Wednesday, July 31st. Stockholders of record on Tuesday, September 3rd will be given a dividend of $0.41 per share on Tuesday, October 1st. This represents a $1.64 annualized dividend and a dividend yield of 1.12%. The ex-dividend date of this dividend is Friday, August 30th. This is a positive change from McKesson's previous quarterly dividend of $0.39. View McKesson's Dividend History.
How were McKesson's earnings last quarter?
McKesson Co. (NYSE:MCK) posted its earnings results on Wednesday, July, 31st. The company reported $3.31 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $3.04 by $0.27. The firm had revenue of $55.73 billion for the quarter, compared to analyst estimates of $54.03 billion. McKesson had a return on equity of 30.73% and a net margin of 0.27%. The business's quarterly revenue was up 5.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.90 earnings per share. View McKesson's Earnings History.
When is McKesson's next earnings date?
What guidance has McKesson issued on next quarter's earnings?
McKesson updated its FY20 earnings guidance on Wednesday, July, 31st. The company provided earnings per share guidance of $14.00-14.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $14.12.
What price target have analysts set for MCK?
10 brokers have issued 12-month target prices for McKesson's shares. Their predictions range from $130.00 to $164.00. On average, they anticipate McKesson's stock price to reach $147.5556 in the next twelve months. This suggests a possible upside of 0.5% from the stock's current price. View Analyst Price Targets for McKesson.
What is the consensus analysts' recommendation for McKesson?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.
Has McKesson been receiving favorable news coverage?
Media stories about MCK stock have trended negative on Friday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. McKesson earned a news impact score of -2.9 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for McKesson.
Are investors shorting McKesson?
McKesson saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 5,675,200 shares, an increase of 17.3% from the July 31st total of 4,838,200 shares. Based on an average trading volume of 1,450,000 shares, the days-to-cover ratio is currently 3.9 days. Currently, 3.1% of the company's stock are short sold. View McKesson's Current Options Chain.
Who are some of McKesson's key competitors?
What other stocks do shareholders of McKesson own?
Who are McKesson's key executives?
McKesson's management team includes the folowing people:
- Mr. John H. Hammergren, Chairman & CEO (Age 60)
- Britt J. Vitalone, CFO & Exec. VP (Age 50)
- Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
- Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
- Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)
Who are McKesson's major shareholders?
McKesson's stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.70%), BlackRock Inc. (8.16%), BlackRock Inc. (8.16%), Invesco Ltd. (2.98%), Boston Partners (2.43%) and Pzena Investment Management LLC (2.07%). Company insiders that own McKesson stock include Brian Scott Tyler, Britt J Vitalone, Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, N Anthony Coles and Sundeep G Reddy. View Institutional Ownership Trends for McKesson.
Which institutional investors are selling McKesson stock?
MCK stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Boston Partners, UBS Group AG, Van ECK Associates Corp, Baupost Group LLC MA, Ruffer LLP, Renaissance Technologies LLC and Quest Capital Management Inc. ADV. Company insiders that have sold McKesson company stock in the last year include Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs and Sundeep G Reddy. View Insider Buying and Selling for McKesson.
Which institutional investors are buying McKesson stock?
MCK stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Royal Bank of Canada, BlackRock Inc., BlackRock Inc., APG Asset Management N.V., Pzena Investment Management LLC, Price T Rowe Associates Inc. MD and Tavio Capital LLC. View Insider Buying and Selling for McKesson.
How do I buy shares of McKesson?
Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is McKesson's stock price today?
One share of MCK stock can currently be purchased for approximately $146.82.
How big of a company is McKesson?
McKesson has a market capitalization of $27.15 billion and generates $214.32 billion in revenue each year. The company earns $34 million in net income (profit) each year or $13.57 on an earnings per share basis. McKesson employs 80,000 workers across the globe.View Additional Information About McKesson.
What is McKesson's official website?
How can I contact McKesson?
McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at investor[email protected]
MarketBeat Community Rating for McKesson (NYSE MCK)
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
